AXVNX
Price
$18.25
Change
+$0.06 (+0.33%)
Updated
Jul 25 closing price
Net Assets
31.59M
VSIAX
Price
$87.39
Change
+$0.46 (+0.53%)
Updated
Jul 25 closing price
Net Assets
55.61B
Interact to see
Advertisement

AXVNX vs VSIAX

Header iconAXVNX vs VSIAX Comparison
Open Charts AXVNX vs VSIAXBanner chart's image
Acclivity Small Cap Value N
Price$18.25
Change+$0.06 (+0.33%)
VolumeN/A
Net Assets31.59M
Vanguard Small Cap Value Index Admiral
Price$87.39
Change+$0.46 (+0.53%)
VolumeN/A
Net Assets55.61B
AXVNX vs VSIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
AXVNX vs. VSIAX commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXVNX is a Buy and VSIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSIAX has more cash in the bank: 55.6B vs. AXVNX (31.6M). VSIAX pays higher dividends than AXVNX: VSIAX (2.11) vs AXVNX (1.01). AXVNX was incepted earlier than VSIAX: AXVNX (7 years) vs VSIAX (14 years). AXVNX (1.27) is less costly to investors than VSIAX (0.07). AXVNX is a more actively managed with annual turnover of: 96.00 vs. VSIAX (16.00). VSIAX has a lower initial minimum investment than AXVNX: VSIAX (3000) vs AXVNX (5000). VSIAX annual gain was more profitable for investors over the last year : 5.03 vs. AXVNX (-7.91). AXVNX return over 5 years is better than : 99.12 vs. VSIAX (88.00).
AXVNXVSIAXAXVNX / VSIAX
Total Expense Ratio0.730.071,043%
Annual Report Gross Expense Ratio1.270.071,814%
Fund Existence7 years14 years-
Gain YTD-2.6232.362-111%
Front LoadN/AN/A-
Min. Initial Investment50003000167%
Min. Initial Investment IRAN/AN/A-
Net Assets31.6M55.6B0%
Annual Yield % from dividends1.012.1148%
Returns for 1 year-7.915.03-157%
Returns for 3 years19.5630.3964%
Returns for 5 years99.1288.00113%
Returns for 10 yearsN/A101.76-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BBIO46.300.64
+1.40%
BridgeBio Pharma
VIRT44.200.43
+0.98%
Virtu Financial Inc
NYMTN21.61N/A
N/A
New York Mortgage Trust
ARCT14.94-0.01
-0.07%
Arcturus Therapeutics Holdings
CELU2.96-0.20
-6.33%
Celularity